tirzepatide shortage fda Lilly's weight-loss drug removed from FDA's list The Tirzepatide Shortage Is Over:

It is not FDA-approved as a finished product but remains legal under patient-specific compounding rules in April 2026 via federal court injunctions

The phenomenon is so common in bariatric surgery patients that dermatologists recognize it as a predictable part of significant weight loss

Some note that patients on niacinamide formulations report slightly better energy levels compared to those on plain semaglutide

Providers often review lifetime weight trends, previous diet attempts, exercise history, and weight regain patterns

Skin reflects what's happening inside the body

Thats because semaglutide restructures how the body recognizes fullness, processes meals, and uses nutrients